FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Antibiotic topics
Antibiotic
Antibiotics
Daptomycin
Antibacterial
Amino Acid
Bacterial Infection
Bacterial Infections
Recombinant
Acne Vulgaris
Vancomycin
Acne Treatment
Chromatograph
Chromatography
Streptomyces
Therapeutical

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Antibiotic patents



      
           
This page is updated frequently with new Antibiotic-related patent applications. Subscribe to the Antibiotic RSS feed to automatically get the update: related Antibiotic RSS feeds. RSS updates for this page: Antibiotic RSS RSS


Date/App# patent app List of recent Antibiotic-related patents
08/28/14
20140243378
 Compositions and methods for the treatment of muscular disease, and related screening methods patent thumbnailnew patent Compositions and methods for the treatment of muscular disease, and related screening methods
Disclosed are methods of treating a muscle disease and improving normal muscle function by administering a therapeutically effective amount of an isoprenoid antibiotic. Also disclosed are methods of upregulating hnrnp l and hnrnp l targets by administering a therapeutically effective amount of an isoprenoid antibiotic.
08/28/14
20140243288
 Fused ring-containing oxazolidinones antibiotics patent thumbnailnew patent Fused ring-containing oxazolidinones antibiotics
The present invention relates to a fused ring-containing oxazolidinone compound shown by general formula (i), a pharmaceutically acceptable salt thereof and a stereoisomer thereof, wherein r1, r2, r3, r4, r5, r6, a, b and c are as defined in the description. The present invention further relates to a method for preparing the compound, a pharmaceutical composition and a pharmaceutical formulation comprising the compound, and a use of the compound for the manufacture of a medicament for the treatment and/or prevention of infectious diseases and a use for the treatment and/or prevention of infectious diseases..
08/28/14
20140243280
 Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable thereby patent thumbnailnew patent Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable thereby
The invention relates to drug development and synthetic chemistry, in particular to the manufacture of biologically active compounds based on naturally occurring molecules. It also relates to novel biologically active compounds, for example aminoglycoside antibiotics, in a substantially pure regioisomeric form..
08/28/14
20140243241
 Method for measuring beta-lactam antibiotics patent thumbnailnew patent Method for measuring beta-lactam antibiotics
The present invention relates to methods for determining the concentration of a free beta-lactam antibiotic in a biological sample. In particular, the present invention relates to methods for measuring a free beta-lactam antibiotic in a biological sample, comprising the steps of: (a) providing at least one class c beta-lactamase, a functional fragment or variant thereof; (b) providing at least one biological sample; (c) contacting said at least one class c beta-lactamase with said at least one biological sample; and (d) determining the concentration of said free beta-lactam antibiotic in said at least one biological sample..
08/28/14
20140242106
 Staphylococcus aureus proteins and nucleic acids patent thumbnailnew patent Staphylococcus aureus proteins and nucleic acids
The invention provides proteins from staphylococcus aureus including amino acid sequences and the corresponding nucleotide sequences. The proteins are useful for vaccines, immunogenic compositions, diagnostics, enzymatic studies and also as targets for antibiotics..
08/28/14
20140242051
 Probiotic, lactic acid-producing bacteria and uses thereof patent thumbnailnew patent Probiotic, lactic acid-producing bacteria and uses thereof
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen..
08/21/14
20140235855
 Tricyclic antibiotics patent thumbnailTricyclic antibiotics
Compounds of formula (i), wherein a1 represents —o—, —s— or —ch2—; a2 represents —ch2— or —o—; a3 represents c3-c8-cycloalkylene; saturated or unsaturated 4 to 8-membered heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen or oxygen, which group a3 is unsubstituted or substituted; a4 represents c1-c4alkylene, —c(=0)-; g represents aryl or heteroaryl, which is unsubstituted or substituted; x1 represents a nitrogen atom or cr1; r1 represents a hydrogen atom or a halogen atom; r1 represents a hydrogen atom; m is 0 or 1; n is 1; the —(ch2)n— group is unsubstituted or substituted; p is 0 or 1; or pharmaceutically acceptable salts thereof are valuable for use as a medicament for the treatment of bacterial infections.. .
08/21/14
20140234889
 Method for neutralization of antibiotics in a culture medium patent thumbnailMethod for neutralization of antibiotics in a culture medium
The present invention is directed to a method and means for the neutralization, binding, and/or inactivation of antimicrobials in a test sample. The invention is also directed to a method of detecting the presence of one or more microorganisms in a test sample by culturing the test sample in a culture media comprising one or more primary amine-containing compounds..
08/21/14
20140234845
 Organism identification panel patent thumbnailOrganism identification panel
Methods and containers are provided for identifying a species, illustratively a bacterial species. Illustrative methods comprise amplifying various genes in the nucleic acid from the bacterial species in a single reaction mixture using pairs of outer first-stage primers designed to hybridize to generally conserved regions of the respective genes to generate a plurality of first-stage amplicons, dividing the reaction mixture into a plurality of second-stage reactions, each using a unique pair of second-stage primers, each pair of second-stage primers specific for a target bacterial species or subset of bacterial species, detecting which of the second-stage reactions amplified, and identifying the bacterial species based on second-stage amplification.
08/21/14
20140234397
 Treatment of klebsiella pneumoniae with liposomally formulated glutathione patent thumbnailTreatment of klebsiella pneumoniae with liposomally formulated glutathione
The composition of the invention, liposomal glutathione, has been recently shown to have utility for having an antibiotic like effect on klebsiella pneumonia cultures in vitro, and in vivo as demonstrated by efficacy in reducing by large multiples the presence of cultures of klebsiella in rats in animal tests. Further, because the liposomal glutathione bolsters body defenses as well as appearing to have direct killing action, the propensity to create more and more resistant strains to antibiotic treatment is downgraded..
08/21/14
20140234227
Foam formulations
The present invention provides foamable pharmaceutical compositions comprising water-soluble antibiotics and anti-inflammatory steroids and methods of preparing same. Particularly, the present invention relates to oil-free pharmaceutical compositions comprising a quinolone, an anti-inflammatory steroid, a polar co-solvent, and propellant gas, administered to the ear in the form of foam for treating ear disorders..
08/21/14
20140230811
Mouthpiece and method for delivering nebulized medicament to the airway of a subject
A mouthpiece (10) is configured to be removably coupled with a nebulizer (12) to deliver nebulized medicament to the airway of a subject. The mouthpiece is configured to connect to the nebulizer in a swappable manner with another mouthpiece that is configured to operate in a continuous use mode.
08/14/14
20140228312
Antibiotic composition and its uses
The present invention relates to a composition comprising: an antibiotic selected from the group consisting of an aminoglycoside antibiotic, a beta-lactam antibiotic, an ansamycin antibiotic, a macrolide antibiotic, a sulfonamide antibiotic, a quinolone antibiotic, an oxazolidinone antibiotic, a glycopeptide antibiotic, and a mixture thereof; and a fatty acid represented by formula (i), a stereoisomer, a salt or an ester thereof, wherein r1 is a substituted or unsubstituted aliphatic group.. .
08/14/14
20140228307
Composition and method for treating an autoimmune disease
A combination of antibiotics including rifabutin, clarithromycin and clofazimine for the treatment of an autoimmune disease such as multiple sclerosis and related diseases. In a further aspect, there is provided a composition comprising a combination of two or more antibiotic agents for the treatment of an autoimmune disease, said two or more antibiotic agents selected from rifabutin, clofazimine, and at least one macrolide..
08/14/14
20140228278
Antibiotics and methods for manufacturing the same
The present invention generally relates to a novel highly discriminating antibiotic, plantazolicin, a plantazolicin-like compound and to pharmaceutical compositions comprising the same. Also provided are methods for producing and using plantazolicin.
08/14/14
20140227716
Biomarkers for respiratory infection
Methods of determining levels of activity of bacteria in the lungs of patients are described, in which levels of a marker of a bacterial iron scavenging processes (for example, siderophores) and levels of a secreted bacterial protein are measured over time. Changes in the measured levels over time allow levels of bacterial activity to be determined, and exacerbations of bacterial infection to be predicted and/or monitored.
08/14/14
20140227353
Pharmaceutical compositions for the treatment of helicobacter pylori
Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by h.
08/14/14
20140224692
Therapeutic rinse
A therapeutic rinse for treating a sore throat. The therapeutic rinse may be stored in a self-heating container that is capable of reaching a temperature of at least 130 degrees fahrenheit when activated.
08/07/14
20140221348
Novel bicyclic antibiotics
X5 represents c—h or c—(c1-c6alkyl), c-halogen; a1, a2, a3, r1 and r4 represent various substituents, g represents aryl or heteroaryl, which is unsubstituted or substituted which compounds show good activity against pathogenic bacteria.. .
08/07/14
20140221330
Ndm inhibitor
An objective of the present invention is to provide a novel ndm (new delhi metallo-β-lactamase) inhibitor that functions as a drug for restoring the antibacterial activity of β-lactam antibiotics that have been inactivated as a result of decomposition by ndm. According to the present invention, there is provided an ndm inhibitor contains a compound represented by general formula (i):.
08/07/14
20140221302
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
The present invention is antibiotic compositions, ventilator based systems and methods relating to ventilator-associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis. Antibiotic combinations of fosfomycin and an aminoglycoside, preferably amikacin, are administered via an in-line nebulizer within the airway of the ventilator.
08/07/14
20140219917
Oligosaccharide conjugates for targeting bacteria and uses related thereto
This disclosure relates to conjugates for targeting bacteria and related uses. In certain embodiments, the disclosure relates to methods of transferring a molecule of interest into bacteria comprising mixing bacteria with a non-naturally occurring conjugate under conditions such that the conjugate is transported across the bacterial cell wall.
07/31/14
20140213567
Tazobactam arginine antibiotic compositions
This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.. .
07/31/14
20140213566
Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
Pharmaceutical compositions and methods for treating or preventing bacterial infections are disclosed. The pharmaceutical compositions typically comprise pharmaceutically effective amount of: (a) at least one beta-lactam antibiotic or a pharmaceutically acceptable salt thereof, (b) sulbactam or a pharmaceutically acceptable salt thereof, and (c) at least one beta-lactamase inhibitor or a pharmaceutically acceptable salt thereof, with the provision that the beta-lactamase inhibitor is not sulbactam..
07/31/14
20140213507
Diagnosis of respiratory tract infectious disease using blood specimens
Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in which a measured value of scd14-st in blood is used as an indication.. .
07/24/14
20140206659
Tazobactam arginine antibiotic compositions
This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.. .
07/24/14
20140206573
Method for evaluating bacterial cell wall integrity
The present invention relates to a method for evaluating the integrity of the cell wall of the bacteria present in a culture in the presence of an antibiotic acting on the bacterial cell wall which, from a practical point of view, allows quickly determining if a bacterium is sensitive or resistant to an antibiotic acting on the bacterial cell wall. Likewise, the present invention also relates to a lysis solution applicable in the preceding method, specifically affecting bacteria having the cell wall damaged by the action of an antibiotic acting on the bacterial cell wall, which allows distinguishing bacteria sensitive to said antibiotic from those resistant to said antibiotic..
07/17/14
20140200197
Hiv protease inhibitors
The compounds encompassed by formula i include compounds which are hiv protease inhibitors and other compounds which can be metabolized in vivo to hiv protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by hiv and the prophylaxis, treatment, or delay in the onset of aids.
07/17/14
20140200193
Thixotropic biological adhesive for use in internal body cavities
A biological thixotropic adhesive that contains dextrin, and at least a structural component that provides thixotropy to the adhesive, and optionally at least an antibiotic that is very useful to stimulate the process of healing of tissues in a patient, for example, to prevent anastomotic leaks of the gastrointestinal system, to affix a prosthesis in inguinal hernioplasties, in a patient and to oclude a fistula in a patient. The biological thixotropic dahesive also has anti-inflammatory properties and can be used with a fatty tissue patch..
07/17/14
20140199375
Combination therapy for skin disorders
The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.. .
07/17/14
20140199289
Use of matrix metalloproteinase inhibitors to treat tuberculosis
The present invention provides a method for treating a subject suffering from tuberculosis which comprises administering to the subject a composition comprising an amount of an inhibitor of a matrix metalloproteinase (mmp) in an amount effective to treat the subject, such that the therapeutic effect of said composition is different than the therapeutic effect attributable to the antibiotic properties of said composition. The present invention also provides a method for reducing or inhibiting destruction of lung extracellular matrix in a subject comprising administering to the subject at risk for such destruction a composition comprising an amount of an inhibitor of a matrix metalloproteinase (mmp) in an amount effective to reduce or inhibit destruction of lung extracellular matrix in the subject..
07/10/14
20140194375
Topical antibiotic composition for the prevention of lyme disease
The invention relates to topical pharmaceutical compositions and methods related to borrelia burgdorferi toxins, in particular, the present invention provides compositions and methods for the treatment of infections caused by borrelia burgdorferi and in particular for the prevention of lyme disease.. .
07/10/14
20140193530
Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug
Provided is a pharmaceutical composition useful for prevention and/or treatment of diseases caused by bacteria, wherein the pharmaceutical composition comprising a honeysuckle extract containing iridoid compounds and an antibiotic. Also provided is a pharmaceutical kit comprising the honeysuckle extract containing the iridoid compounds and the antibiotics which are separately placed.
07/10/14
20140193372
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
The present invention provides for microbial compositions and methods for reducing the concentration of short-chain fatty acids in the gut as a way to reduce energy uptake and manage obesity. More specifically, the invention provides for decreasing short-chain fatty acids available for absorption in the human gut, such as acetate, using one or more of: a probiotic including a homo-acetogenic, acetate oxidizing bacterium that converts acetate to h2; a probiotic including an acetoclastic methanogen; a microbial electrolysis cell comprising a homo-acetogenic bacterium and/or an acetoclastic methanogen; a prebiotic that enhances the growth or function of acetate-scavenging microbiota; or a highly selective antibiotic that targets h2-oxidizing methanogens..
07/03/14
20140188033
Drug delivery using a sacrificial host
Implantable drug-doped component, e.g., a cochlear implant, including host material, a host-embedded drug, a sacrificial material integrated with the host. Sacrificial material facilitates release of drug from the component.
07/03/14
20140187780
6,11-bridged biaryl macrolides
Which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment.
07/03/14
20140187528
Tazobactam arginine antibiotic compositions
This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.. .
07/03/14
20140187512
Use of lactulose in the treatment of autism
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria.
07/03/14
20140187475
Lantibiotic compositions and methods for preventing or treating mastitis
A composition suitable for application to the skin comprising at least one lantibiotic, an acidic external phase aqueous solution, at least one pharmaceutically acceptable internal phase carrier material, and a combination thereof. A method for preventing or treating mastitis, comprising administering to a human in need of such treatment a topical composition comprising a therapeutically-effective amount of at least one lantibiotic, an acidic aqueous solution, and at least one pharmaceutically acceptable carrier material..
07/03/14
20140187446
Affinity-based detection of biological targets
A method of biochemical identification by: providing a plurality of capture species bound to one or more substrates and suspected of having one or more biological targets affinity bound to at least one capture species; detecting which capture species contain bound biological targets to generate a binding pattern; and identifying the biological target based on the binding pattern. The capture species are independently selected from the group consisting of antimicrobial peptides, cytotoxic peptides, antibiotics, and combinations thereof.
07/03/14
20140187443
Antibacterial and plasmid elimination agents
Inhibitors of the tmrna pathway have antibacterial activity with broad species specificity, including b. Anthracis and other pathogens of military and civilian interest.
07/03/14
20140186873
Synthesis and use of isotopically labeled macrocyclic compounds
Disclosed herein are isotopically labeled antifungal antibiotics and related compounds. Also disclosed are methods for synthesizing these isotopically labeled molecules and using the same to study the distribution of these compounds in the biosphere as well as the products formed by the breakdown of these isotopically labeled compounds..
07/03/14
20140186269
Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active agents for the treatment of human skin, especially in the treatment of acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, p. Acne bacteria associated disorders, and other superficial infections, including skin infections..
06/26/14
20140179929
Synthesis of enone intermediate
The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics.
06/26/14
20140179691
Novel oxazolidinone derivative and medical composition containing same
The novel oxazolidinone derivative, the prodrug thereof, the hydrate thereof, the solvate thereof, the isomer thereof, and the pharmaceutically acceptable salt thereof have broad antibacterial spectrum against resistant bacteria, low toxicity and strong antibacterial effects against gram-positive and gram-negative bacteria and thus may be effectively used as antibiotics.. .
06/26/14
20140179594
Streptococcus bacteriophage lysins for treatment of gram positive bacteria in companion animals and livestock
The present invention provides methods for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria in companion animals and livestock, including streptococcus and staphylococcus bacterial strains, including pathogenic and antibiotic-resistant bacteria, and related conditions. The methods of the invention utilize plyss2 and/or plyss1 lytic enzymes and variants thereof, including truncations thereof.


Popular terms: [SEARCH]

Antibiotic topics: Antibiotic, Antibiotics, Daptomycin, Antibacterial, Amino Acid, Bacterial Infection, Bacterial Infections, Recombinant, Acne Vulgaris, Vancomycin, Acne Treatment, Chromatograph, Chromatography, Streptomyces, Therapeutical

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Antibiotic for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Antibiotic with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4015

3483

71 - 0 - 72